ClinicalTrials.Veeva

Menu

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

V

Vantive Health LLC

Status

Completed

Conditions

Chronic Kidney Disease

Treatments

Device: Polyflux 210H dialyzer
Device: Polyflux HD-C4

Study type

Interventional

Funder types

Industry

Identifiers

NCT00636389
Gambro 1460

Details and patient eligibility

About

The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device.

The objectives of this study are:

  1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and,
  2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults 18 years of age or older
  • Stable hemodialysis prescription using Polyflux 210H or Polyflux 21R for at least 2 months prior to study enrollment
  • Dialyzing through a native fistula or Gore-Tex graft.
  • Blood access must be able to provide a blood flow rate of 400 ml/min.

Exclusion criteria

  • Non-compliance with dialysis
  • Hematocrit less than 28%
  • Active Infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 2 patient groups

HD-C4 First, then 210H
Other group
Description:
Subjects will be randomly assigned to begin the first week of three consecutive treatments with the Polyflux HD-C4 dialyzer. Following the third treatment, the subjects will be switched to the Polyflux 210H dialyzer for a second week of three consecutive treatments. Therefore each subject will have a total of six consecutive dialysis treatments.
Treatment:
Device: Polyflux HD-C4
Device: Polyflux 210H dialyzer
210H First, then HD-C4
Other group
Description:
Subjects will be randomly assigned to begin the first week of three consecutive treatments with the Polyflux 210H dialyzer. Following the third treatment, the subjects will be switched to the Polyflux HD-C4 dialyzer for a second week of three consecutive treatments. Therefore each subject will have a total of six consecutive dialysis treatments.
Treatment:
Device: Polyflux HD-C4
Device: Polyflux 210H dialyzer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems